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TT virus (TTV) is an unenveloped, single-stranded, circular-DNA virus which resembles members of the Circoviridae, that
is commonly found in humans and which lacks pathological consequences for the infected host. TTV replication has been
demonstrated in bone marrow cells but not in peripheral blood mononuclear cells (PBMC), suggesting that hematopoietic
cells must be activated to support TTV replication. To test this hypothesis, PBMC from two naturally TTV-infected individuals
and from two healthy TTV-DNA negative donors infected in vitro with a TTV-DNA-positive serum were cultured in the
presence (stimulated) or absence (unstimulated) of phytohemagglutinin, lipopolysaccharide, and interleukin-2. TTV-DNA was
detected in both stimulated and unstimulated PBMC. However, TTV-DNA replicative intermediates and mRNA were detected
only in stimulated PBMC. Furthermore, TTV-DNA and mRNA were detected in PBMC from two TTV negative donors
reinfected with supernatants from TTV-infected stimulated cells but not when using culture supernatants from unstimulatedINTRODUCTION
In 1997, a new virus named TT virus (TTV) was
isolated from the serum of a patient with posttransfu-
sional hepatitis of unknown etiology (Nishizawa et al.,
1997). However, later studies in both humans and
nonhuman primates have shown that TTV viremia is
not associated with the development of chronic liver
disease (Luo et al., 2000; Matsumoto et al., 1999;
Mizokami et al., 2000; Watanabe et al., 1999). TTV is an
unenveloped virus whose genome consists in a circu-
lar, single-stranded DNA molecule of negative polarity
of about 3.8 kb in length (Mushahwar et al., 1999).
Based on its physicochemical and genomic character-
istics, it has been proposed that TTV may be a new
member of the Circoviridae family of viruses (Taka-
hashi et al., 1998). Analysis of the TTV transcription
pattern in COS-1 (Kamahora et al., 2000) and bone
marrow cells (Okamoto et al., 2000a) has revealed the
existence of at least three species of spliced mRNA
molecules of 2.9–3, 1.2, and 1.0 kb in length, with
common 5 and 3 termini, leading to the creation of
two new open reading frames (ORF3 and ORF4) in
addition to the previously described ORF1 and ORF2
(Okamoto et al., 1998).
1 To whom correspondence and reprint requests should be ad-
dressed at Fundacio´n para el Estudio de las Hepatitis Virales,The putative protein encoded by the ORF1 possesses
a N-terminal arginine-rich hydrophilic region and two of
the four conserved motifs of the Rep protein which in
Circoviruses are implicated in the viral DNA replication
via a rolling-circle mechanism (Mushahwar et al., 1999).
This suggests that TTV may replicate using the same
strategy.
Regarding target organs for TTV infection, TTV-DNA has
been detected by both PCR and in situ hybridization in liver
and peripheral blood mononuclear cells (PBMC) (Lopez-
Alcorocho et al., 2000; Okamura et al., 1999; Rodriguez-
Inigo et al., 2000). In this regard, TTV-DNA fragments of 3.5
to 6.1 kb in length which are resistant to S1 nuclease
digestion and which may represent circular, double-
stranded TTV-DNA replicative intermediates compatibles
with a rolling-circle replication mechanism have been de-
tected in the liver of TTV-infected patients (Okamoto et al.,
2000b). On the contrary, these replicative intermediates
have not been detected in PBMC, suggesting that although
TTV infects these cells, it cannot replicate in PBMC. How-
ever, the same replicative intermediates have been found in
bone marrow cells from TTV-infected patients (Okamoto et
al., 2000a). This finding could indicate that TTV only repli-
cates in cells of hematopoietic origin when activated. To
test this hypothesis, we have studied the presence of TTV-
DNA replicative intermediates in stimulated and unstimu-
lated PBMC from two healthy donors infected in vitro with
the TTV and in naturally TTV infected PBMC from two TTVcells. These results demonstrate that TTV replicates in PB
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Detection of TTV-DNA in in vitro infected and
naturally infected PBMC
TTV-DNA was positive in the cellular DNA fraction as
well as in the cultures supernatants of in vitro infected
stimulated PBMC from the two donors at 4 h postinfec-
tion and at 7, 14, 21, and 30 days of culture. In the in vitro
infected unstimulated PBMC, TTV-DNA was positive in
the cellular DNA fraction at 4 h postinfection and after 7
days of culture. However, in this case, TTV-DNA was not
detected in the cell culture supernatants (Fig. 1A).
Regarding the naturally infected PBMC, as in the case
of in vitro infected cells, TTV-DNA was positive in both
the cellular DNA fraction and the supernatants of stimu-
lated PBMC at 4 h and 7 days of culture, while in un-
stimulated cells TTV-DNA was detected only in the cel-
lular DNA but not in the cell culture supernatants (Fig.
1B).
In all cases the PBS washes of the cells always tested
TTV-DNA negative. Furthermore, no viral DNA was de-
tected in the cellular DNA fraction nor in the superna-
tants of the PBMC incubated with the TTV-DNA-negative
serum sample.
On the other hand, treatment of the cells with trypsin
and DNase I before total DNA isolation did not abolish
the TTV-DNA detection in the cellular DNA fraction (Fig.
1C), suggesting that the amplified viral DNA did not come
from viral particles passively attached to the cell mem-
brane.
To further confirm the intracellular localization of TTV,
PBMC cultures infected in vitro, naturally infected and
PBMC incubated with the TTV-DNA negative serum were
analyzed by fluorescent in situ hybridization. As shown in
Fig. 2, positive hybridization signals were detected in the
cytoplasm of both in vitro infected and naturally infected
PBMC, but not in the cells incubated with the TTV-DNA-
negative serum sample. The specificity of the in situ
hybridization was also confirmed by the lack of signals
when the cells were hybridized with the vector alone,
when the cells were digested with DNase I prior to the
hybridization, or when the probe was omitted from the
hybridization solution (data not shown).
Detection of TTV replicative intermediates and TTV-
RNA in in vitro infected and naturally infected PBMC
To confirm that TTV replicates in stimulated in vitro
and naturally infected PBMC but not in nonstimulated
cells, total DNA from the cells and the corresponding
culture supernatants was isolated and electrophoresed.
In both naturally infected and in vitro infected stimulated
PBMC, TTV-DNA was positive in the DNA fraction mi-
grating at 2 to 4 and 4.5 to 6 kb (Fig. 3B). When the total
DNA was digested with S1 nuclease (which digests
single-stranded DNA) prior to the TTV-DNA detection, the
viral DNA was only amplified in the DNA fraction migrat-
ing at 4.5 to 6 kb (Fig. 3C). In contrast, when the total
DNA was predigested with NdeI (there is one NdeI target
sequence in the amplified ORF1 fragment), TTV-DNA
remained positive only in the DNA fraction migrating at 2
to 4 kb (Fig. 3D).
In nonstimulated PBMC (naturally infected and in vitro
infected), TTV-DNA was only amplified in the DNA frac-
tion migrating at 3.5 to 4 kb (Fig. 3E). This TTV-DNA was
FIG. 1. TTV-DNA detection by PCR (using primers derived from the
ORF1) in in vitro infected PBMC cultures. (A) Total DNA isolated from
unstimulated PBMC at 4 h (lane 1) and 7 days (lane 1) postinfection.
Lanes 2 and 2: Cell culture supernatants. Lanes 3 and 3: PBS washes
of PBMC before total DNA isolation. (B) Total DNA isolated from PBMC
stimulated with PHA, LPS, and IL-2 at 4 h, 7, 14, 21, and 30 days
postinfection (lanes 1). Lanes 2: Cell cultures supernatants of stimu-
lated PBMC. Lanes 3: PBS washes of the cells before total DNA
isolation. (C) TTV-DNA detection in the PBS washes of the cells before
(lane 1) and after (lane 2) trypsin and DNase digestion of the PBMC.
Lane 3: Total DNA isolated from the PBMC after trypsin and DNase
treatment. Lane 4: Total DNA from non-infected PBMC. Lane 5: Positive
control (TTV-DNA positive serum). Lane 6: Negative control (TTV-DNA
negative serum). Mw: molecular weight marker (100-bp DNA ladder,
Gibco-BRL).
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FIG. 2. TTV-DNA and RNA detection by FISH in naturally and in vitro infected PBMC after 1 week of culture. In vitro infected PHA, LPS, and IL-2
stimulated PBMC (1, 1); naturally infected stimulated PBMC (2, 2); in vitro infected unstimulated PBMC (3, 3); naturally infected unstimulated PBMC
(4, 4); PBMC incubated with a TTV-DNA negative serum sample (5, 5). Counterstained with DAPI. Original magnification, 1000.
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sensitive to S1 nuclease digestion but resistant to NdeI
digestion.
Regarding culture supernatants from stimulated
PBMC, TTV-DNA (sensitive to S1 nuclease but resistant
to NdeI digestion) was detected only in the DNA fraction
migrating at 3.5 to 4 kb (Fig. 3F). In contrast, TTV-DNA
was not detected in the supernatants from nonstimulated
cells.
It is important to remark that in stimulated PBMC, the
single-stranded TTV-DNA was detected in the DNA frac-
tions migrating at 2 to 4 kb that represents the putative
single-stranded replicative intermediates while in non-
stimulated cells as well as in the culture supernatants
from stimulated cells. TTV-DNA was only amplified in the
DNA fraction migrating at 3.5 to 4 kb, which is compatible
with the circular single-stranded TTV-DNA form found in
the TTV virions.
These results demonstrated the presence of single-
and double-stranded TTV-DNA forms in both in vitro
infected and naturally infected stimulated PBMC, while
only single-stranded TTV-DNA was detected in non-
stimulated cells and in the cultures supernatants from
stimulated cells.
Furthermore, the presence of TTV-RNA in stimulated
and unstimulated cells (naturally and in vitro infected)
was tested by RT-PCR and fluorescent in situ hybridiza-
tion. TTV-RNA was detected by RT-PCR in the poly(A)
RNA isolated from stimulated PBMC (in vitro and natu-
rally infected) but not in nonstimulated cells or in the
culture supernatants (Fig. 4). In regards to the detection
of TTV-RNA by fluorescent in situ hybridization, positive
hybridization signals were detected using the riboprobe
of negative polarity in stimulated PBMC but not in un-
stimulated cells (Fig. 2). Furthermore, no hybridization
signals were seen in stimulated and unstimulated cells
when the hybridization was performed using the ribo-
probe of positive polarity, when the samples were di-
gested with RNase A before the hybridization, and when
the probe was omitted from the hybridization solution
(data not shown).
Infection of PBMC with supernatants from in vitro
infected and naturally infected PBMC cultures
Finally, to study whether the TTV-DNA detected in the
supernatant of stimulated in vitro and naturally infected
PBMC cultures corresponded to truly TTV infectious par-
ticles, supernatants from these cultures were used to
reinfect in vitro PBMC from two TTV-DNA negative do-
nors. As control, culture supernatants from unstimulated
PBMC (either in vitro infected and naturally infected)
were also used to reinfect TTV-DNA negative PBMC.
After 1 week of culture TTV-DNA and RNA were de-
tected only in the PBMC incubated with the supernatants
from stimulated cells (Fig. 5). In contrast, neither TTV-
DNA nor RNA were detected in the PBMC incubated with
the supernatants from unstimulated cells.
These results show that stimulation of TTV-infected
PBMC is necessary for the release of viral particles to
the culture supernatants.
DISCUSSION
Despite several reports that have shown that TTV
viremia may persist indefinitely (Lefrere et al., 2000; Ma-
tsumoto et al., 1999), the target cells for TTV replication
remain largely unknown. TTV-DNA has been detected by
PCR and in situ hybridization in liver and lymphoid cells
from patients with TTV-DNA detectable in serum (Lopez-
Alcorocho et al., 2000; Okamura et al., 1999; Rodriguez-
FIG. 3. Southern analysis of PCR products obtained after TTV-DNA
amplification of the DNA extracted from the different gel slices after
electrophoresis of the total DNA isolated from the samples. (A) Sche-
matic representation of the gel indicating the molecular weight of the
DNA in each gel slice. (B) Undigested total DNA from in vitro infected,
stimulated (PHA, LPS, and IL-2) PBMC after 1 week of culture. (C) Total
DNA isolated from in vitro infected stimulated PBMC after 1 week of
culture, digested with S1 nuclease. (D) Total DNA isolated from in vitro
infected stimulated PBMC after 1 week of culture, digested with NdeI.
(E) Undigested total DNA isolated from in vitro infected unstimulated
PBMC after 1 week of culture. (F) Undigested total DNA isolated from
the supernatants of in vitro infected stimulated PBMC after 1 week of
culture. NEG: Total DNA isolated from a TTV-DNA negative serum
sample. POS: Total DNA isolated from a TTV-DNA positive serum
sample.
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Inigo et al., 2000). However, the putative replicative in-
termediate of the virus has been detected in liver and
bone marrow cells but not in PBMC (Okamoto et al.,
2000a,b). This finding could indicate that the TTV-DNA
detected in PBMC corresponds to viral particles pas-
sively attached to the cell membrane or that the virus
infects hematopoietic cells but only replicates when
these cells are activated. To distinguish between these
two possibilities, in this study we have analyzed the
presence of TTV-DNA replicative intermediates as well
as TTV-RNA in stimulated and unstimulated PBMC either
naturally infected by TTV or in vitro infected with a TTV-
DNA-positive serum sample.
When the presence of TTV-DNA was analyzed in stim-
ulated and unstimulated PBMC (naturally or in vitro in-
fected), the viral DNA was detected in both the culture
supernatants and the total DNA fraction isolated from the
cells in the stimulated PBMC, while in unstimulated cells,
TTV-DNA was positive only in the cellular DNA fraction.
The presence of TTV-DNA in the supernatants of stimu-
lated cells but not in that of unstimulated PBMC sug-
gests that viral replication with liberation of viral particles
to the culture medium only occurs in stimulated PBMC.
By contrast, in unstimulated PBMC, the detection of TTV-
DNA only in the cellular DNA fraction could indicate that
the detected viral DNA may come from viral particles
tightly attached to the cell membrane or form nonrepli-
cating virus infecting the PBMC. To distinguish between
these two possibilities, the stimulated and nonstimulated
PBMC were treated with trypsin and DNase before ex-
traction of the cellular DNA. This treatment did not abol-
ish the TTV-DNA detection in the cellular DNA fraction
from both stimulated and nonstimulated PBMC, indicat-
ing that at least part of the TTV-DNA was intracellularly
located independently if the cells were stimulated or not.
This hypothesis was confirmed by the results obtained
by in situ hybridization that clearly showed the presence
of TTV-DNA in the cytoplasm of stimulated and unstimu-
lated infected PBMC. Taken together these results show
that although TTV is able to infect resting PBMC, the
FIG. 4. Detection by RT-PCR of TTV-mRNA and -actin mRNA in in vitro infected and naturally infected PBMC after 1 week of culture. (1, 1) mRNA
isolated from naturally infected PBMC stimulated with PHA, LPS, and IL-2; (2, 2) mRNA isolated from naturally infected stimulated PBMC after RNase
digestion; (3, 3) mRNA isolated from in vitro infected stimulated PBMC; (4, 4) mRNA isolated from in vitro infected PBMC after RNase digestion; (5,
5) mRNA isolated from naturally infected unstimulated PBMC; (6, 6) mRNA isolated from in vitro infected unstimulated PBMC. (a) Positive control:
TTV-RNA transcribed in vitro from the pCR-ORF1 plasmid. (b) Negative control: Poly(A) RNA isolated from PBMC of a TTV-DNA negative donor. (c)
Positive control: poly(A) RNA isolated from the HepG2 hepatoma cell line. (d) Negative control: poly(A) RNA isolated from HepG2 cells treated with
RNase prior the RT-PCR reaction. Mw: molecular weight marker (100-bp DNA ladder, Gibco-BRL).
FIG. 5. TTV-DNA (A) and RNA (B) detection by PCR and RT-PCR,
respectively, in PBMC from two different donors (a and b) incubated
with culture supernatants from stimulated (S) and unstimulated (U)
PBMC infected in vitro with the TTV. Mw: molecular weight marker
(100-bp DNA ladder, Gibco-BRL).
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virus replicates only when these cells are stimulated. To
further confirm this hypothesis, the presence of the pu-
tative replicative intermediates of the viral DNA as well
as the existence of TTV-mRNA were also investigated in
stimulated and unstimulated PBMC either naturally or in
vitro infected. In stimulated PBMC, TTV-DNA was de-
tected in the DNA fraction migrating at 2 to 4 kb and at
4.5 to 6 kb. The TTV-DNA detected in the former DNA
fraction was resistant to NdeI digestion but sensitive to
S1 nuclease digestion, indicating that it was single
stranded. By contrast, the viral DNA detected in the later
DNA fraction was resistant to the S1 nuclease digestion
but sensitive to NdeI digestion, indicating that it was
double stranded. These findings are in agreement with
previous reports on the detection of the putative TTV-
DNA replicative intermediates in liver and bone marrow
cells (Okamoto et al., 2000a,b). By contrast, in unstimu-
lated cells, the TTV-DNA was positive only in the DNA
fraction migrating at 3.5 to 4 kb, being sensitive to S1
nuclease digestion but resistant to NdeI digestion, indi-
cating that the detected TTV-DNA was single stranded.
Furthermore, TTV-mRNA was detected by both RT-PCR
and in situ hybridization in stimulated but not in non-
stimulated PBMC. Finally, TTV infection was successfully
transmitted to uninfected PBMC using as inocula the
culture supernatants from TTV-infected stimulated
PBMC, showing that these cells released infectious viral
particles. In agreement with these findings, recently
Maggi and co-workers (2001) have shown that the TTV-
titers increased along time in the culture supernatants
from stimulated PBMC infected in vitro with the TTV.
In conclusion, our results show that TTV is able to
infect PBMC but only replicates and releases viral parti-
cles when these cells are activated. In this regard it is
important to note that the UTR of the TTV genome con-
tains putative binding sites for transcription factors such
as NF- and Sp1 that are activated by LPS or IL-2
(Arima et al., 1992; Muller et al., 1993; Nicolet et al., 1998).
Furthermore, as TTV replicates only in activated PBMC
and the percentage of circulating activated cells is very
low (Baars et al., 1995; Hamann et al., 1997), this may be
the cause for the lack of detection of TTV replicative
intermediates in freshly isolated PBMC from TTV-in-
fected patients.
MATERIALS AND METHODS
Isolation and preparation of cells
PBMC from two healthy donors with normal liver func-
tion tests without TTV-DNA in serum and without mark-
ers of hepatitis C, B, and D viruses and from two indi-
viduals with normal liver function tests but with TTV-DNA
in serum and in PBMC (one of the patients was infected
with the TTV 1a genotype while the other was infected
with the TTV 1b genotype) were isolated from 30 ml of
heparinized blood by centrifugation on Ficoll–Hypaque
gradients (Seromed; Biochrom KG, Berlin, Germany),
washed twice with phosphate-buffered saline (PBS), and
resuspended in RPMI 1640 culture medium (Imperial
Laboratories, Andover, U.K.) supplemented with 10%
heat-inactivated fetal bovine serum (Imperial Laborato-
ries), 20 mM HEPES, and 2 mM glutamine. Prior to the
culture, cell viability was determined by the trypan blue
exclusion test.
In vitro infection of PBMC
The PBMC from the two TTV-DNA negative donors
were adjusted to a density of 107 viable cells/ml of
culture medium. Then, 107 viable cells from each donor
were seeded in petri dishes (Corning Inc., Corning, NY)
and stimulated with 10 g/ml of phytohemagglutinin
(PHA) (Sigma Chemical Co., St. Louis, MO) and 10 g/ml
of Escherichia coli lipopolysaccharide (LPS) (Sigma
Chemical Co.) for 48 h at 37°C in a humidified atmo-
sphere containing 5% CO2. After incubation, PBMC were
counted and adjusted to a density of 107 viable cells/ml
of RPMI 1640 culture medium supplemented with 20
IU/ml recombinant human interleukin-2 (IL-2) (Chiron-
Cetus Corp., Emeryville, CA). Two other aliquots of 107
cells from each donor were cultured under the same
conditions but in the absence of PHA, LPS, and IL-2.
Stimulated and unstimulated cells were seeded into
24-well culture plates at a density of 4  106 viable cells
per well and incubated with 10 l of serum from a TTV
DNA-positive patient (infected with the TTV 1a genotype)
without markers of infection caused by any other hepa-
totropic virus in RPMI 1640 medium with (stimulated
cells) or without (unstimulated cells) IL-2 for 4 h at 37°C
in a humidified atmosphere with 5% CO2. After incuba-
tion, the cells were washed three times with PBS and the
cultures were maintained at a density of 2 106 cells per
well. The last PBS was saved to be used as the negative
control for TTV-DNA detection by PCR. The culture me-
dium of the stimulated cells was changed weekly for a
1-month period. At each medium change, PBMC were
counted and two-thirds of the cells were divided into
three aliquots (two aliquots for DNA and RNA extraction,
respectively, and the other for TTV-DNA detection by in
situ hybridization) and stored at 80°C until use. The
supernatants were filtered through 0.22-m filters (MIL-
LEX-GP, Millipore, Bedford, MA), aliquoted, and stored at
80°C until use. The remaining one-third of the PBMC
was subcultured with two-thirds of fresh cells extracted
from the same healthy blood donor.
Unstimulated PBMC-infected in vitro with TTV were
cultured for 1 week and then harvested. The PBMC and
supernatants were aliquoted and frozen at 80°C until
use. As negative control, stimulated and unstimulated
PBMC from the two healthy donors were incubated with
a TTV-DNA-negative serum sample and cultured under
the same experimental conditions described above.
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In vitro infection of PBMC with culture supernatants
One aliquot of 100 l from each culture supernatant
from both stimulated and unstimulated cells was thawed
and used as inoculum to infect in vitro stimulated and
unstimulated PBMC from the two healthy donors under
the same conditions as described above. After 1 week of
culture, the medium was removed and the cells were
collected and frozen at 80°C until use.
Culture of PBMC from TTV-DNA-positive patients
PBMC from the two TTV-DNA-positive patients were
aliquoted at a density of 107 viable cells/ml of RPMI. One
aliquot was cultured under stimulation as described
above and the other aliquot was cultured in the absence
of PHA, LPS, or IL-2. After 1 week, the medium was
removed, aliquoted, and stored at80°C. The cells were
washed three times with PBS (the last wash was saved
to be used as negative control), collected, aliquoted, and
frozen at 80°C until use. This process was repeated
three more weeks in the case of stimulated cells.
Detection of TTV-DNA by PCR
Total DNA was isolated from the PBMC and culture
supernatants by digestion with proteinase K (1 mg/ml)
and sodium dodecyl sulfate (SDS) (1%), as described
previously (Lopez-Alcorocho et al., 2000). After phenol
extraction and ethanol precipitation, the DNA was resus-
pended in 20 l of sterile distilled demonized water and
aliquoted. TTV-DNA in PBMC and supernatants was de-
tected by PCR using the primers set NG061 (nucleotides
1900–1923) and NG063 (nucleotides 2161–2185) from
TTV-ORF1, following the method described by Okamoto
et al. (1999). The nucleotide positions of the primers are
referred to the sequence of the TA278 isolate (GenBank
Accession No. AB008394) (Table 1).
The TTV-DNA detection by PCR was performed in
PBMC samples and culture supernatants from the first,
second, third, and fourth weeks of cultures in the case of
stimulated cells and from the first week in the case of
unstimulated cells.
Detection of TTV replicative intermediates
The presence of TTV replicative intermediates in
PBMC and supernatants from the first and the fourth
week of culture was determined following the method
described by Okamoto et al. (2000a). Briefly, DNA ex-
tracted from these samples was electrophoresed on 1.5%
agarose gels in parallel with a DNA size marker (500-bp
DNA Ladder, Gibco-BRL Life Technologies, Gaithers-
burg, MD). After electrophoresis, the region of the gel
covering from 1.5 to 6 kb was cut into slices at 500-bp
intervals. DNA was eluted from each slice and divided
into three aliquots. One aliquot was not treated and the
other two were digested with 1 U of S1 nuclease (Gibco-
BRL) for 15 min at 37°C or with 1 U of the restriction
endonuclease NdeI (Promega Co., Madison, WI) for 1 h
at 37°C, respectively. After treatment, DNA was phenol
extracted and ethanol precipitated and the ORF1 was
amplified by PCR as described above. After amplifica-
tion, PCR products were electrophoresed on 1.5% aga-
rose gels and the DNA was transferred onto nylon mem-
branes (Hybond-N, Amersham Pharmacia Biotech,
Uppsala, Sweden). The membranes were prehybridized
for 2 h at 70°C with a prehybridization mix containing
0.5% SDS, 5 Denhardt’s solution (1 Denhardt’s solu-
tion: 0.02% bovine serum albumin, 0.02% polyvinylpyrro-
lidone, 0.02% Ficoll), 5 SSC (20 SSC: 3 M NaCl, 0.3 M
sodium citrate), and 0.1 mg/ml sonicated salmon sperm
DNA. The plasmid pCR-ORF1, which contains a 270-bp
PCR product of the TTV-DNA ORF1 cloned in the pCRII-
TOPO vector (Invitrogen Corp., San Diego, CA), was used
as probe. The plasmid was labeled with digoxigenin-11-
dUTP (Boehringer Mannheim Biochemicals, Indianapo-
lis, IN) by nick-translation (Gibco-BRL) and the hybridiza-
tion was carried out overnight at 42°C with 200 ng of
heat-denaturated labeled probe in a mixture containing
50% demonized formamide, 5 SSC, 0.5% SDS, 0.01 M
Tris pH 8.0, 0.15 mg/ml bovine serum albumin, and 0.1
mg/ml sonicated salmon sperm DNA. After hybridization,
the membranes were washed at 42°C in 2 SSC fol-
lowed by 0.5 SSC and 0.1 SSC (15 min each).
The digoxigenin-labeled hybrids were detected using
TABLE 1
Primers Used in PCR and RT-PCR for the Detection of TTV-DNA and -Actin mRNA
Name nt sequence (5 to 3) nt position Size (bp)
TTV ORF1
Sense NG061 GGCAACATGYTRTGGATAGACTGG 1915–1938
270
Antisense NG063 CTGGCATTTTACCATTTCCAAAGTT 2161–2185
-actin
Sense B1 AGCGGGAAATCGTGCGTG 2279–2296
311
Antisense B2 CAGGGTACATGGTGGTGCC 2570–2589
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the DIG Nucleic Acid Detection kit (Boehringer Mann-
heim) following the manufacturer’s instructions. To con-
firm the intracellular localization of the TTV-DNA, cul-
tured cells at 7 days postinfection were washed tree
times with PBS (the last wash was saved to be used as
a negative control). Then, the PBMC were treated with
0.05% trypsin (Gibco-BRL) and 0.02% EDTA in PBS at
37°C for 30 min. After incubation, the trypsin digestion
was stopped by adding fetal bovine serum and the cells
were further treated with 1 U of RQ1 DNase (Promega
Co.) for 30 min at 37°C. Finally cells were centrifuged at
130 g for 10 min. Total DNA from the PBS wash, the
supernatant, and the cell pellet was extracted and TTV
was amplificated by PCR using the primers from the
ORF1 as described above.
Detection of TTV-RNA by RT-PCR
Poly(A) RNA was extracted from PBMC and culture
supernatants from the first and the fourth week of culture
using the Micro-Fast Track 2.0 mRNA Isolation kit (In-
vitrogen, Carlsbad, CA), following the manufacturer’s in-
structions. The contaminating DNA was removed from
the samples by digestion for 1 h at 37°C with 10 units of
DNase I/RNase free (Roche Diagnostics Co., Indianapo-
lis, IN). After phenol extraction and ethanol precipitation,
the poly(A) RNA concentration was estimated by mea-
suring the absorbance at 260 nm. One microgram of
poly(A) RNA isolated from PBMC or the total poly(A)
RNA isolated from the supernatants was amplified using
a one-step reverse-transcription PCR method (Tth DNA
Polymerase, Promega Co.) with the primers NG061 and
NG063 as described above. With this set of primers, only
the 2.9-kb TTV-mRNA can be amplified. As control for the
integrity of the mRNA, the -actin mRNA was amplified
by using the same RT-PCR method with the primers B1
and B2 (Table 1).
Detection of TTV-DNA and RNA by fluorescent in situ
hybridization (FISH)
The presence of TTV-DNA in the PBMC from the first
week of culture was carried out by in situ hybridization as
previously described (Lopez-Alcorocho et al., 2000) ex-
cept that the slides were digested with 2 g/L of RNase
A (Sigma Co.) at 37°C for 2 h before hybridization. The
pCR-ORF1 plasmid labeled with digoxigenin-11-dUTP by
nick-translation was used as probe. After washing, the
slides were counterstained with 0.6 g/ml of 4,6-di-
amino-2-phenyllindole (ONCOR, Appligene, Heidelberg,
Germany). Specificity of the hybridization signals was
assessed by hybridization with the pCRII-TOPO vector
alone by omitting the probe in the hybridization mixture
and by digestion with DNase I (2 g/l) at 37°C for 2 h
before hybridization. The images were visualized and
captured with a Nikon Eclipse E-400 microscope.
For detection of TTV-RNA by FISH, riboprobes of both
sense and antisense polarity were generated. For that
purpose the pCR-ORF1 plasmid was linearized by diges-
tion with XbaI or HindIII. The linearized plasmids were
transcribed in vitro using the SP6 (XbaI linearized plas-
mid) or T7 (HindIII linearized plasmid) RNA polymerases
in the presence of digoxigenin-11-UTP (DIG RNA Label-
ing mix, Boehringer Mannheim) to generate probes of
antisense (to be used as specificity control) and sense
(to detect TTV-mRNA) polarity, respectively.
Hybridization was carried out as described (Lopez-
Alcorocho et al., 2000), except that slides were digested
with DNase I (2 g/l) for 2 h at 37°C before hybridiza-
tion, using 200 ng of labeled probe per slide.
Signal specificity was assessed by digestion of the
samples with RNase A (2 g/L) for 2 h at 37°C before
hybridization, by omission of the probe in the hybridiza-
tion solution, and by hybridization with the riboprobe of
antisense polarity. After washing, the slides were coun-
terstained with 0.6 g/mL of 4,6-diamino-2-phenyl-
lindole (ONCOR).
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